Scientists have uncovered the chemical mechanism behind protein release from the ribosome, clarifying how all living ...

All living organisms' genetic information is stored in DNA, which is transcribed into RNA, which is translated into proteins ...

Conventional small-molecule drugs interact with a target protein to alter its activity. However, the activities of many therapeutically relevant proteins cannot be modified using small molecules ...

This review explores how generative AI, through models like VAEs, GANs, transformers, and diffusion networks is ...

A recent study led by a team of researchers at The Johns Hopkins University School of Medicine examining aging mice has ...

If the patient needs more therapeutic protein, then he/she would take more tetracycline to boost production. To stop production of the therapeutic protein, the patient stops taking tetracycline.

A leftover from microbes’ meals is linked to early heart disease in people. In mice, it contributed to plaque buildup in the arteries.

In that basement lab, Quigley and his small team at Leash Bio produced about 133 million data points of small molecules binding to protein targets. Earlier this year, they released that data as ...

The researchers observed that the small molecule they’d identified, which they named WEHI-3773, inhibited BAX’s ability to break the cell’s mitochondria, preventing its death.

For an expanded technical preview, click here. “Our vision is to make protein interactions programmable,” said Luca Naef, Co-Founder & CTO of VantAI who led the development of Neo-1.